Aldosterone receptor antagonists for heart failure: Current status, future indications

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.

Bertram Pitt, MD
University of Michigan School of Medicine, Ann Arbor, MI; investigator in the RALES, EPHESUS, and 4E trials

Sanjay Rajagopalan, MD
Mt. Sinai School of Medicine, New York, NY

Address: Sanjay Rajagopalan, MD, One Gustave Levy Place, Box 1030, New York, NY 10029; e-mail sanjay.Rajagopalan@mssm.edu

Dr. Pitt has indicated that he serves as a consultant for the Pfizer corporation.